Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.

Thornburg NJ, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley RM, Bombardi RG, Yu Y, Graham S, Branchizio A, Yoder SM, Rock MT, Creech CB, Edwards KM, Lee D, Li S, Wilson IA, García-Sastre A, Albrecht RA, Crowe JE Jr.

J Clin Invest. 2016 Apr 1;126(4):1482-94. doi: 10.1172/JCI85317. Epub 2016 Mar 7.

2.

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation.

Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE Jr.

Haematologica. 2016 May;101(5):e204-8. doi: 10.3324/haematol.2015.139501. Epub 2016 Jan 27. No abstract available.

3.

Small intestinal intraepithelial TCRγδ+ T lymphocytes are present in the premature intestine but selectively reduced in surgical necrotizing enterocolitis.

Weitkamp JH, Rosen MJ, Zhao Z, Koyama T, Geem D, Denning TL, Rock MT, Moore DJ, Halpern MD, Matta P, Denning PW.

PLoS One. 2014 Jun 6;9(6):e99042. doi: 10.1371/journal.pone.0099042. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105487.

4.

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE Jr.

Exp Hematol. 2012 Dec;40(12):974-982.e1. doi: 10.1016/j.exphem.2012.08.002. Epub 2012 Aug 10.

5.

Development and validation of novel enzyme activity methods to assess inhibition of matrix metalloproteinases (MMPs) in human serum by antibodies against enzyme therapeutics.

Edkins TJ, Alhadeff JA, Kwok V, Kalensky C, Rock MT, Vidmar TJ, Del Tito BJ Jr.

J Pharm Biomed Anal. 2012 Nov;70:408-14. doi: 10.1016/j.jpba.2012.06.012. Epub 2012 Jun 28.

PMID:
22854133
6.

Association between obesity and vulnerability and serologic response to influenza vaccination in older adults.

Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, Shay DK, Belongia EA, Griffin MR.

Vaccine. 2012 Jun 6;30(26):3937-3943. doi: 10.1016/j.vaccine.2012.03.071. Epub 2012 Apr 3.

7.

Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios.

Weitkamp JH, Koyama T, Rock MT, Correa H, Goettel JA, Matta P, Oswald-Richter K, Rosen MJ, Engelhardt BG, Moore DJ, Polk DB.

Gut. 2013 Jan;62(1):73-82. doi: 10.1136/gutjnl-2011-301551. Epub 2012 Jan 20.

8.

Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity.

Engelhardt BG, Jagasia SM, Crowe JE Jr, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M.

Blood. 2012 Mar 8;119(10):2417-21. doi: 10.1182/blood-2011-10-384750. Epub 2012 Jan 19.

9.

A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.

Goins WP, Edwards KM, Vnencak-Jones CL, Rock MT, Swift M, Thayer V, Schaffner W, Talbot TR.

Clin Infect Dis. 2012 Apr;54(7):938-45. doi: 10.1093/cid/cir973. Epub 2012 Jan 11.

10.

Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Kapasi A, Meade BD, Plikaytis B, Pawloski L, Martin MD, Yoder S, Rock MT, Coddens S, Haezebroeck V, Fievet-Groyne F, Bixler G, Jones C, Hildreth S, Edwards KM, Messonnier NE, Tondella ML.

Clin Vaccine Immunol. 2012 Jan;19(1):64-72. doi: 10.1128/CVI.05460-11. Epub 2011 Nov 23.

11.

Machine learning competition in immunology - Prediction of HLA class I binding peptides.

Zhang GL, Ansari HR, Bradley P, Cawley GC, Hertz T, Hu X, Jojic N, Kim Y, Kohlbacher O, Lund O, Lundegaard C, Magaret CA, Nielsen M, Papadopoulos H, Raghava GP, Tal VS, Xue LC, Yanover C, Zhu S, Rock MT, Crowe JE, Panayiotou C, Polycarpou MM, Duch W, Brusic V.

J Immunol Methods. 2011 Nov 30;374(1-2):1-4. doi: 10.1016/j.jim.2011.09.010. Epub 2011 Sep 29. No abstract available.

PMID:
21986107
12.

Identification of potential human respiratory syncytial virus and metapneumovirus T cell epitopes using computational prediction and MHC binding assays.

Rock MT, McKinney BA, Yoder SM, Prudom CE, Wright DW, Crowe JE Jr.

J Immunol Methods. 2011 Nov 30;374(1-2):13-7. doi: 10.1016/j.jim.2011.08.004. Epub 2011 Aug 11.

13.

Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.

Sutherland JN, Chang C, Yoder SM, Rock MT, Maynard JA.

Clin Vaccine Immunol. 2011 Jun;18(6):954-62. doi: 10.1128/CVI.00561-10. Epub 2011 Apr 20.

14.

Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin.

Talbot HK, Rock MT, Johnson C, Tussey L, Kavita U, Shanker A, Shaw AR, Taylor DN.

PLoS One. 2010 Dec 28;5(12):e14442. doi: 10.1371/journal.pone.0014442.

15.

Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomes.

Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, Jiang A, Kassim AA, Lu P, Schuening F, Yoder SM, Rock MT, Crowe JE Jr.

Bone Marrow Transplant. 2011 Mar;46(3):436-42. doi: 10.1038/bmt.2010.127. Epub 2010 May 31.

16.

Immunogenicity and safety of intradermal influenza vaccination in healthy older adults.

Chi RC, Rock MT, Neuzil KM.

Clin Infect Dis. 2010 May 15;50(10):1331-8. doi: 10.1086/652144.

PMID:
20377407
17.

Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.

Khurana S, Chearwae W, Castellino F, Manischewitz J, King LR, Honorkiewicz A, Rock MT, Edwards KM, Del Giudice G, Rappuoli R, Golding H.

Sci Transl Med. 2010 Jan 20;2(15):15ra5. doi: 10.1126/scitranslmed.3000624.

18.

T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.

Austin ED, Rock MT, Mosse CA, Vnencak-Jones CL, Yoder SM, Robbins IM, Loyd JE, Meyrick BO.

Respir Med. 2010 Mar;104(3):454-62. doi: 10.1016/j.rmed.2009.10.004. Epub 2009 Oct 31.

19.

Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers.

Wright PF, Durbin AP, Whitehead SS, Ikizler MR, Henderson S, Blaney JE, Thumar B, Ankrah S, Rock MT, McKinney BA, Murphy BR, Schmidt AC.

Am J Trop Med Hyg. 2009 Nov;81(5):834-41. doi: 10.4269/ajtmh.2009.09-0131.

20.

Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination.

Reif DM, Motsinger-Reif AA, McKinney BA, Rock MT, Crowe JE Jr, Moore JH.

Genes Immun. 2009 Mar;10(2):112-9. doi: 10.1038/gene.2008.80. Epub 2008 Oct 16.

21.

Genetic basis for adverse events after smallpox vaccination.

Reif DM, McKinney BA, Motsinger AA, Chanock SJ, Edwards KM, Rock MT, Moore JH, Crowe JE.

J Infect Dis. 2008 Jul 1;198(1):16-22. doi: 10.1086/588670. Erratum in: J Infect Dis. 2008 Sep 1;198(5):796.

22.

Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.

Lee S, Miller SA, Wright DW, Rock MT, Crowe JE Jr.

J Virol. 2007 Mar;81(5):2349-58. Epub 2006 Dec 20.

23.

Cytokine expression patterns associated with systemic adverse events following smallpox immunization.

McKinney BA, Reif DM, Rock MT, Edwards KM, Kingsmore SF, Moore JH, Crowe JE Jr.

J Infect Dis. 2006 Aug 15;194(4):444-53. Epub 2006 Jul 13.

24.

Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine.

Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE Jr.

J Infect Dis. 2006 Aug 15;194(4):435-43. Epub 2006 Jul 7.

PMID:
16845626
25.

Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.

Rutigliano JA, Rock MT, Johnson AK, Crowe JE Jr, Graham BS.

Virology. 2005 Jul 5;337(2):335-43.

26.

Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses.

Chen X, Rock MT, Hammonds J, Tartaglia J, Shintani A, Currier J, Slike B, Crowe JE Jr, Marovich M, Spearman P.

J Virol. 2005 May;79(9):5537-47.

27.

Differential regulation of granzyme and perforin in effector and memory T cells following smallpox immunization.

Rock MT, Yoder SM, Wright PF, Talbot TR, Edwards KM, Crowe JE Jr.

J Immunol. 2005 Mar 15;174(6):3757-64.

28.

Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial.

Talbot TR, Stapleton JT, Brady RC, Winokur PL, Bernstein DI, Germanson T, Yoder SM, Rock MT, Crowe JE Jr, Edwards KM.

JAMA. 2004 Sep 8;292(10):1205-12. Erratum in: JAMA. 2004 Nov 24;292(20):2470.

PMID:
15353533
29.

Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels.

Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE Jr.

J Infect Dis. 2004 Apr 15;189(8):1401-10. Epub 2004 Apr 5.

PMID:
15073677
31.

Use of optical biosensor technology to study immunological cross-reactivity between different sulfonamide drugs.

Ahmad A, Ramakrishnan A, McLean MA, Li D, Rock MT, Karim A, Breau AP.

Anal Biochem. 2002 Jan 15;300(2):177-84.

PMID:
11779109
32.

Beta1 integrin-mediated T cell adhesion and cell spreading are regulated by calpain.

Rock MT, Dix AR, Brooks WH, Roszman TL.

Exp Cell Res. 2000 Nov 25;261(1):260-70.

PMID:
11082296
34.

Historical ranges: obfuscating perambulators of statistical graffiti or useful tools?

Rock MT, Khan KN.

Toxicol Pathol. 1997 Nov-Dec;25(6):651-2. No abstract available.

PMID:
9437813
35.

Supplemental Content

Support Center